NCT02431728View on ClinicalTrials.gov

The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Substance Withdrawal Syndrome
Interventions
DIETARY_SUPPLEMENT

Melatonin

5 mg capsule p.o. at bedtime daily

DIETARY_SUPPLEMENT

Matched Placebo

5 mg capsule p.o. at bedtime daily

Trial Locations (1)

15233

Salvation Army Harbor Light Center, Pittsburgh

All Listed Sponsors
lead

Duquesne University

OTHER

NCT02431728 - The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program | Biotech Hunter | Biotech Hunter